Abstract:
The present application relates to isothiazolylidene containing compounds of Formula (I) wherein R1, R2, R3, R4, and L are as defined in the specification, compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions.
Abstract:
The present application relates to isothiazolylidene containing compounds of Formula (I) wherein R1, R2, R3, R4, and L are as defined in the specification, compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions.
Abstract:
Se describen ligandos de receptor canabinoide de la fórmula (I), en donde Y, X1, X2, X3, R1 y R2 son tal como se define en la especificación: También se describen composiciones que comprenden dichos compuestos, y métodos para tratar condiciones y trastornos utilizando dichos compuestos y composiciones.